Dear AuntMinnie Member,
CT plays an important role in the management of lung cancer patients, as it can accurately describe the condition and organ status of the disease in detail and thus help clinicians best plan treatment. In this month's featured story, we're highlighting research that demonstrates how CT volumetric imaging analysis can help determine pre- and postoperative lung function in lung cancer patients undergoing pulmonary lobectomy. Get all the details here.
After you've read that story, navigate over to our CT content area for more coverage of the modality, especially its use in lung cancer screening (LCS). Check out our report on a study that showed how a clinical practice LCS program found more disease than the National Lung Screening Trial -- which indicates that the burden of lung cancer is higher in the screening population than in clinical trials -- as well as four more stories that demonstrate how a new risk prediction model, patient consultation with a radiologist, and tailored screening improve LCS uptake and how deep learning can flag patients at further risk of the disease.
We're also showcasing research that describes how CT-FFR reduces invasive procedures for coronary artery blockages and how the modality reveals the influence of diabetes on COVID-19 severity. Finally, take a look at our articles about findings that suggest that understanding the mechanics of flow artifacts on CT or CT angiography is key to better disease diagnosis and that interstitial lung abnormalities may be linked to respiratory disease risk.
Keep up to date on CT's many uses and innovations by visiting our CT content area often. And if you have CT-related topics you'd like us to consider, please contact me.
